Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

SYSTEMIC VASCULITIS SCREEN

Geisinger Epic Procedure Code:  LAB5191    Geisinger Epic ID:  196776

SPECIMEN COLLECTION
Specimen type: 

Serum


Preferred collection container: 
Alternate collection container: 
6 mL red-top (plain, non-serum separator) tube
Specimen required: 

0.5 mL serum; minimum 0.5 mL



SPECIMEN PROCESSING
Processing instructions: 

Allow to clot. Centrifuge and submit 0.5 mL serum.


Transport temperature: 

Refrigerated (preferred). Room temperature (stable 8 hours) and frozen specimens also acceptable.


Specimen stability: 

Room temperature: 8 hours. 2-8°C: 48 hours. Frozen: 6 months.


Rejection criteria: 

Specimen stability exceeded; specimen grossly hemolyzed.



TEST DETAILS
Reference interval: 

MPO Antibody Negative <3.5 U/mL
PR3 Antibody Negative <2.0 U/mL


Interpretation guide: 

Anti-MPO: Negative <3.5 U/mL 
Equivocal 3.5- 5.0 U/mL 
Positive >5.0 U/mL

Anti-PR3: Negative <2.0 U/mL 
Equivocal 2.0-3.0 U/mL
Positive >3.0 U/mL

If either MPO or PR3 result is “equivocal”, test progresses to ANCA-IFA at an additional charge.


CPT code(s):  86037x2
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

anti-MPO, anti-PR3 antibody detection


Methodology: 
Enzyme Immunoassay (EIA)
Synonyms: 

myeloperoxidase, proteinase 3, ANCA, MPO, anti-MPO, PR3, anti-PR3, ANCA Battery, ANCAB


Clinical significance: 

The presence of anti-neutrophil associated antibodies (ANCA) can be used in conjunction with other tests and clinical findings to aid in the assessment of systemic vasculitis. This panel tests for the two most common anti-neutrophil antibodies, anti-myeloperoxidase (MPO) and anti-proteinase 3 (PR3). Anti-PR3 is more commonly associated with Granulomatosis with Polyangiitis (GPA, formerly known as Wegener's Granulomatosis), while anti-MPO is commonly associated with Microscopic Polyangiitis (MPA), although there is considerable overlap in positivity between conditions. Antineutrophil antibodies can also be observed in related ANCA-associated vasculitides (AAV) such as pauciimmune-necrotizing crescentic glomerulonephritis and Churg–Strauss syndrome, and is also seen in some patients with other autoimmune conditions such as IBD, PSC, and RA. For follow-up and trending of known cases, the appropriate stand-alone antibody test (anti-MPO LAB2730 or anti-PR3 LAB2942) should be used. If anti-MPO/PR3 are negative but strong clinical suspicion of autoimmune vasculitis remains, or for follow-up of known MPO/PR3-negative, ANCA-positive vasculitis, stand-alone ANCA-IFA can be ordered (LAB5192)


Doctoral Director(s): 
Benjamin Andress, PhD, DABCC
Hoi-Ying Elsie Yu, PhD, DABCC, FADLM
Review Date:  05/21/2025

Performing Locations